中国创新药又多了一种暴富的游戏

健识局
31 Jan

2025年,创新药出海仍在继续。继License-in之后,中国医药投资市场又迎来新模式。1月20日,康诺亚与诺诚健华联合宣布:两家公司及合营企业,与Prolium生物科技公司就一款抗肿瘤新药CM355的商业化合作签订协议。根据双方协议:Prolium公司将拥有CM355在全球范围内非肿瘤适应症,以及肿瘤适应症则享受亚洲以外地区的开发、注册、生产及商业化的独家权利。而康诺亚和诺诚建华将平分最高...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10